HPLC法测定门冬氨酸钾镁注射液中门冬氨酸有关物质及含量
HPLC determination of aspartate in potassium aspartate and magnesium aspartate injection and its related substances
分类号:R917
出版年·卷·期(页码):2018,38 (3):477-484
DOI:
10.16155/j.0254-1793.2017.01.01
-----摘要:-------------------------------------------------------------------------------------------
目的:建立门冬氨酸钾镁注射液中门冬氨酸有关物质含量测定的HPLC方法。方法:采用SPHERISORB NH2柱(4.6 mm×250 mm,5μm);流动相为乙腈-0.05 mol·L-1的磷酸二氢钾(60:40);流速为1.0 mL·min-1;检测波长为210 nm;柱温为30℃,进样量为5μL;对最大单个杂质采用在线二维脱盐HPLC与MS联用进行初步推断。结果:在该选定色谱条件下,主峰与有关物质峰分离度良好;门冬氨酸在0.338 64~3.386 4 mg·mL-1浓度范围内线性关系良好(r=0.999 8);平均回收率为99.6%(n=9),检测限为23.5 ng;初步推断最大单个杂质为富马酸。结论:本方法专属、灵敏、简便,可用于测定门冬氨酸钾镁注射液中门冬氨酸含量和有关物质。
-----英文摘要:---------------------------------------------------------------------------------------
Objective: To establish an HPLC method for the determination of aspartate in potassium aspartate and magnesium aspartate injection and its related substances.Methods: The separation was performed on a Waters SPHERISORB NH2(4.6 mm×250 mm,5μm)column with the mobile phase consisting of acetonitrile-0.05 mol·L-1 phosphate solution(60:40) at the flow rate of 1.0 mL·min-1.The detection wavelength was set at 210 nm.The column temperature was 30℃.The volume of injection was 5 μL.On-line two-dimensional desalting HPLC/MS was applied to infer the maximum single impurity preliminarily.Results: Under above conditions,the main peak and the peaks of the related substances were well separated.Aspartate had a good linear relationship (r=0.999 8) within the range of 0.338 64-3.386 4 mg·mL-1.The average recovery (n=9) was 99.6%.The limit of the detection was 23.5 ng.The maximum single impurity in related substances was preliminarily inferred as fumaric acid.Conclusion: The method is sensitive,specific and simple.It can be used for determining aspartate in potassium aspartate and magnesium aspartate injection and its related substances.
-----参考文献:---------------------------------------------------------------------------------------
欢迎阅读《药物分析杂志》!您是该文第 842位读者!